Global Alzheimer Disease Marketing Lead /Boston

UCB Inc.; Boston (MA); Hybrid; USD 184,000 - 242,000; Full time

Job summary

UCB Inc. is seeking a Global Alzheimer's Disease Marketing Lead (Director-level) to join the Stakeholder Integration team. The role is hybrid, based in one of Atlanta, GA; Raleigh, NC; or Boston, MA, with relocation packages available.

You will shape commercialization for a post-proof-of-concept asset, building market and patient insights to inform development and commercial choices. Collaboration across functions and geographies is essential to define strategy and value proposition.

Qualifications

• Bachelor's degree required.
• 10+ years of pharmaceutical strategy, marketing, or commercialization experience.
• 2+ years Alzheimer's disease or dementia experience.
• 2+ years supporting a development-stage, post-proof-of-concept, or pre-launch asset.

Responsibilities

• Build Alzheimer's disease knowledge and translate insights into asset choices.
• Lead the global cross-functional forum for learning, collaboration and commercial decision making.
• Develop the patient population and indication vision, value proposition, positioning, and commercialization strategy.
• Define market-development priorities to support future adoption, including diagnosis, biomarkers, referral and treatment pathways.

Skills

Strategic thinking

Cross-functional leadership

Insights-driven

Stakeholder management

Commercial strategy

Education

Bachelor's degree

Job description

Make your mark for patients

We are looking for a strategic, collaborative, and insights-driven Global Alzheimer's Disease Marketing Lead (Director-level) to join our Stakeholder Integration team, based in UCB's offices in one of the following locations: Atlanta, GA, Raleigh, NC or Boston, MA. This is a hybrid role, not remote, and relocation packages are available.

About the role

You will shape commercialization of a post-proof-of-concept asset in Alzheimer's disease. Bringing direct disease-area experience, you will build UCB's understanding of the market, patients, caregivers, diagnosis, biomarkers, and healthcare system, and translate it into development and commercial choices. You will work with the Global Stakeholder Integrator, who leads overall commercial sand cross-functional integration. You will work with the Global Stakeholder Integrator, who leads overall commercial strategy and cross-functional integration

Who you'll work with

You will work closely with the Global Stakeholder Integrator and cross-functional colleagues responsible for commercial strategy, asset development, evidence generation, patient access, and investment decisions. You will lead collaboration and commercial decision-making across functions and geographies while bringing external stakeholder perspectives into asset strategy.

What you'll do

• Build UCB's Alzheimer's disease knowledge and translate patient, caregiver, stakeholder, diagnostic, access, and competitive insights into asset choices.
• Lead the global cross-functional forum for learning, collaboration and commercial decision making.
• Develop the patient population and indication vision, value proposition, positioning, and commercialization strategy.
• Define the market-development priorities required to support future adoption, including diagnosis, biomarkers, referral and treatment pathways, healthcare infrastructure, and care delivery.
• Develop market assessments, forecasts, business cases, and commercialization scenarios, including key assumptions, uncertainties, and capability needs.
• Support evaluation of development and partnering scenarios through commercial assessment of strategic options, assumptions, opportunities, and risks.
• Bring external stakeholder perspectives into asset decisions and translate the work into clear recommendations for the Asset team.

Interested? For this role, we're looking for the following:

Minimum Requirements

• Bachelor's degree.
• 10+ years of pharmaceutical strategy, marketing, or commercialization experience.
• 2+ years direct Alzheimer's disease or dementia experience.
• 2+ years experience supporting a development-stage, post-proof-of-concept, or pre-launch asset.

Preferred Requirements

• Experience developing market assessments, forecasts, scenarios, or business cases
• Strong understanding of Alzheimer's diagnosis, biomarkers, stakeholders, and treatment pathways.
• U.S. pharmaceutical commercialization experience.
• Global pharmaceutical strategy or commercialization experience.
• Experience supporting partnered or co-development assets.
• Strong business judgment and ability to synthesize incomplete information.
• Demonstrated success leading through influence across functions and geographies.

This positions reasonably anticipated base salary range is $184,000.00 - $242,000.00 The actual salary offered will take into account related knowledge, skills, experience and location among other factors and may fall outside the expected range.

Are you ready to 'go beyond' to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!

About us

UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science.

Why work with us?

At UCB, we don't just complete tasks, we create value. We aren't afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We 'go beyond' to create value for our patients, and always with a human focus, whether that's on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.

At UCB, we've embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless explicitly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.

UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable federal, state, or local law. UCB invites you to voluntarily self-identify during the application process. Provision of self-identification information is entirely voluntary and a decision to provide or not provide such information will not have any effect on your application for employment, your employment with UCB, or otherwise subject you to any adverse treatment. Any information you provide will be considered confidential and will be kept separate from your application and/or personnel file and will only be used in accordance with applicable laws, orders, and regulations.